These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 14702150)

  • 41. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
    Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Neuroimmunol; 2000 Jan; 102(2):208-15. PubMed ID: 10636490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
    Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
    Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.
    Bieganowska K; Höllsberg P; Buckle GJ; Lim DG; Greten TF; Schneck J; Altman JD; Jacobson S; Ledis SL; Hanchard B; Chin J; Morgan O; Roth PA; Hafler DA
    J Immunol; 1999 Feb; 162(3):1765-71. PubMed ID: 9973440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
    Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
    J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.
    Jacobson S
    J Infect Dis; 2002 Dec; 186 Suppl 2():S187-92. PubMed ID: 12424696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives.
    Shohat M; Shohat B; Mimouni D; Pauli G; Ellerbrok H; David M; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):372-8. PubMed ID: 16882177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Starling AL; Martins-Filho OA; Lambertucci JR; Labanca L; de Souza Pereira SR; Teixeira-Carvalho A; Martins ML; Ribas JG; Carneiro-Proietti AB; Gonçalves DU
    Acta Trop; 2013 Jan; 125(1):75-81. PubMed ID: 23022356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
    Montanheiro P; Vergara MP; Smid J; da Silva Duarte AJ; de Oliveira AC; Casseb J
    J Neuroimmunol; 2007 Aug; 188(1-2):138-42. PubMed ID: 17588676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N; Jacobson S; Leist T; Waldmann TA
    J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease.
    Saito M; Usuku K; Arimura K; Izumo S; Osame M; Ohara Y
    J Neurol Sci; 2008 Mar; 266(1-2):13-9. PubMed ID: 17884099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from northeast Iran (Mash-had).
    Rafatpanah H; Pravica V; Farid R; Abbaszadegan MR; Tabatabaei A; Goharjoo A; Etemadi MM; Hutchinson IV
    Hum Immunol; 2004 Aug; 65(8):839-46. PubMed ID: 15336785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement.
    Kawabata T; Higashimoto I; Takashima H; Izumo S; Kubota R
    J Med Virol; 2012 Jul; 84(7):1120-7. PubMed ID: 22585731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
    Perandin F; Cariani A; Bonfanti C; Trainini L; Magoni M; Manca N
    Neurol Sci; 2006 Sep; 27(4):257-60. PubMed ID: 16998729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
    Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
    Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
    Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.